Magance cutar Alzheimer da Dementia tare da masu tabin hankali

A KYAUTA Kyauta 2 | eTurboNews | eTN
Written by Linda Hohnholz

MYND Life Sciences Inc. ta sanar da cewa ta samu nasarar rufe kan ciniki da aka sanar a baya don samun haƙƙi, take da sha'awa da kuma haƙƙin mallakar fasaha don amfani da masu ilimin hauka don kula da Dementia ("Kayayyakin Da Aka Samu") daga Cava Healthcare Inc. ("Cava"), wani kamfani na kimiyyar rayuwa da ke Surrey, British Columbia. Sayen ya haɗa da duk haƙƙoƙin duniya na gaba da suka shafi amfani da masu tabin hankali don magance cutar Alzheimer da sauran cututtukan hauka.

A kan rufe MYND ya ba da hannun jari na gama gari 450,000 ("Shares") ga Cava akan farashin $0.85 a kowace kaso kuma ya biya kuɗin kuɗi na $120,000 a matsayin la'akari da Kaddarorin da Aka Samu. Bugu da kari, MYND za ta biya wa Cava sarautar shekara-shekara daidai da mafi girman: (i) $240,000; ko (ii) 4% na tallace-tallacen yanar gizo na kowane samfur ko sabis wanda kai tsaye ko a kaikaice ya haɗa Abubuwan da Aka Samu ga kowane ɓangare na uku.

Hannun hannayen jarin za su kasance ƙarƙashin wa'adin riƙewa na doka wanda zai ƙare a ranar da ta kasance watanni huɗu (4) da kwana ɗaya daga ranar rufewa.

Dementia wani mummunan yanayin neurodegenerative ne wanda ke haifar da lalatawar fahimta mai tsanani a cikin tsofaffi kuma yana daɗaɗawa tare da shekaru. Hukumar lafiya ta duniya ta yi kiyasin cewa tsakanin mutane miliyan 44 zuwa 50 a duniya na fama da cutar hauka. Kimanin kudin da ake kashewa na kula da masu fama da ciwon hauka, gami da cutar Alzheimer, a Amurka kadai, ya kai dala biliyan 305 a shekarar 2020 (source: Alzheimer's Association) kuma ana sa ran ya kai dala tiriliyan 1.1 nan da shekara ta 2050. Yawan Amurkawa da ke fama da cutar Alzheimer. ana hasashen kusan sau uku nan da shekarar 2050 sai dai idan ba a sami ci gaba a fannin kula da lafiya ba. MYND na da niyyar kasancewa a sahun gaba na waɗannan ci gaban.

"Rashin ciwon hauka, gami da cutar Alzheimer, yana shafar kusan dukkan iyalai ta wata hanya, yawanci tare da sakamako mai ban mamaki da raɗaɗi," in ji Dokta Lyle Oberg, MD, Shugaba na MYND. "Yayin da muke ci gaba da jawo sha'awar masu zuba jari, za mu iya ɗaukar matakai masu ma'ana don matsawa fiye da daidaitaccen aiki kuma zuwa aikin asibiti tare da ƙungiyar binciken mu." 

Sayen shine mahimmin alamar ƙasa ga MYND kuma yana ginawa akan ƙwarewar MYND a cikin sashin taimakon ilimin halin ɗan adam na psilocybin, gami da hanyoyin magance bakin ciki mai jure wa, ƙarƙashin jagorancin Dr. Lyle Oberg, MD, Shugaba na MYND.

Mista Theo Warkentin, Shugaba na Cava, ya bayyana, “MYND ƙwararren shugaban masana'antu ne a cikin ilimin halin ɗan adam, hanyoyin kwantar da hankali da bincike. Kamfanin yana da matsayi na musamman don biyan tasirin psilocybin da sauran masu ilimin hauka don magance cutar hauka."

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

  • Sayen shine mahimmin alamar ƙasa ga MYND kuma yana ginawa akan ƙwarewar MYND a cikin sashin taimakon ilimin halin ɗan adam na psilocybin, gami da hanyoyin magance bakin ciki mai jurewa, ƙarƙashin jagorancin Dr.
  • Hannun hannayen jarin za su kasance ƙarƙashin wa'adin riƙewa na doka wanda zai ƙare a ranar da ta kasance watanni huɗu (4) da kwana ɗaya daga ranar rufewa.
  • Kimanin kudin kula da mutanen da ke fama da ciwon hauka, gami da cutar Alzheimer, a cikin Amurka kawai, ya kasance dala biliyan 305 mai ban mamaki a cikin 2020 (tushen.

<

Game da marubucin

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...